Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study
Open Access
- 25 February 2021
- Vol. 76 (10), 1032-1035
- https://doi.org/10.1136/thoraxjnl-2020-216078
Abstract
End points that are repeatable and sensitive to change are important in pulmonary arterial hypertension (PAH) for clinical practice and trials of new therapies. In 42 patients with PAH, test–retest repeatability was assessed using the intraclass correlation coefficient and treatment effect size using Cohen’s d statistic. Intraclass correlation coefficients demonstrated excellent repeatability for MRI, 6 min walk test and log to base 10 N-terminal pro-brain natriuretic peptide (log10NT-proBNP). The treatment effect size for MRI-derived right ventricular ejection fraction was large (Cohen’s d 0.81), whereas the effect size for the 6 min walk test (Cohen’s d 0.22) and log10NT-proBNP (Cohen’s d 0.20) were fair. This study supports further evaluation of MRI as a non-invasive end point for clinical assessment and PAH therapy trials. Trial registration number NCT03841344.Funding Information
- Wellcome Trust (205188/Z/16/Z, 206632/Z/17/Z)
- GlaxoSmithKline (BIDS3000032592, COL100041816)
This publication has 10 references indexed in Scilit:
- Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial HypertensionJACC: Cardiovascular Imaging, 2020
- Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)Pulmonary Circulation, 2019
- Clinical trial design and new therapies for pulmonary arterial hypertensionEuropean Respiratory Journal, 2019
- Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2017
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Heart Journal, 2015
- Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAsFrontiers in Psychology, 2013
- Progressive Right Ventricular Dysfunction in Patients With Pulmonary Arterial Hypertension Responding to TherapyJournal of the American College of Cardiology, 2011
- ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centreEuropean Respiratory Journal, 2011
- Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonanceAmerican Heart Journal, 2004